cMET expression correlates with liver metastasis of UM and tumor mutational burden in lung cancer patients, and cMET/HGF signaling has been shown to upregulate indoleamine-2,3-dioxygenase (IDO) 1, a highly immunosuppressive molecule involved in resistance to immunotherapy (35, 56–58). This evidence concerns the gene MET and neoplasm.